Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Premix signs $79.9 million contract for a new production facility in the U.S.

The major agreement will help secure critical diagnostic supplies in the United States and better serve Premix’s global customers.

Gastonia / Helsinki, May 9, 2022 – The U.S. Department of Defense, working with the Department of Health and Human Services, awarded a $79.9 million contract to Premix, Inc. to establish a plastic compound manufacturing plant in North Carolina. The facility will primarily produce plastic materials for diagnostic testing. The facility will be built in Gaston County, centrally located in the growing region of advanced manufacturing in the southeast U.S. and is planned to be operational by September 2025.

“Our hard work in building resilient supply chains, high product quality and consistency pays off as the U.S. government awarded Premix the deal to build a local manufacturing site,” says Hanna Ristola, Managing Director of Premix Group.

Family-owned Finnish-based Premix Group is a market leader and global forerunner in electrically conductive plastics. During the COVID-19 pandemic Premix ensured global PRC tests by securing the availability of the electrically conductive plastic resin that is used to manufacture pipette tips. The new state-of-the-art facility will produce plastic compounds primarily suitable for pipette tips to meet the growing demand and stringent quality requirements for diagnostic testing. The increased production capacity will result in material for pipette tips enabling more than 200 million COVID-19 PCR tests monthly.

“The new capacity will improve Premix’s global supply capability and mitigate risks in global supply chains,” says Jari-Matti Mehto, President and CEO of Premix, Inc. “With the new U.S. factory, we will improve our ability to serve our customers in the important U.S. market.”

Premix’s customers in North America will enjoy local production and services, ensuring faster delivery speed and high reliability. Current and future customers elsewhere in the world will benefit from Premix’s ability to deliver high-quality materials from two different continents.

Don't miss out on any breaking news or insightful opinions!
Subscribe to our free newsletter and stay updated on the go!

By submitting this form, you are consenting to receive marketing emails from: Global Banking and Finance Review, Alpha House, Greater London, SE1 1LB, https://www.globalbankingandfinance.com/. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

When fully operational, the facilities will employ about 30-35 people in Gaston County, North Carolina, as well as support additional jobs with service providers and subcontractors both during the construction and while operational. Some recruitment has already begun.

“We are extremely excited about this opportunity to help secure a supply of critical diagnostic materials in the United States,” says Mehto. “Our solutions meet strict standards for quality and cost-efficiency and provide valuable benefits to our new and existing customers.

Premix, Inc. is a U.S. company and subsidiary of Premix Oy, a 40+ -year-old Finnish company. The agreement was funded through the American Rescue Plan Act to enable and support U.S. domestic industrial base expansion for critical medical resources. It is a result of a strong working relationship between Premix and federal, state, and local authorities and economic development organizations in the United States.

About Premix

Premix is a market leader and global forerunner in electrically conductive plastics. Our tailored material solutions benefit industries such as automotive, electronics, diagnostics, and health & wellbeing. We are a family-owned business who believe in keeping our promises, appreciating our partners, and working with inspiration and passion for a better future. www.premixgroup.com


Recent Post: